Benzinga - Gainers
- MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.
- Yunji Inc. (NASDAQ: YJ) gained 83.8% to $0.39 after reporting first-quarter financial results.
- U Power Limited (NASDAQ: UCAR) shares climbed 65.4% to $12.55. U Power shares jumped 144% on Thursday after the company announced it entered into a framework strategic cooperation agreement with Quantum Solutions Co in Japan.
- Minerva Surgical, Inc. (NASDAQ: UTRS) gained 60% to $0.32.
- Kaixin Auto Holdings (NASDAQ: KXIN) climbed 33.3% to $0.40.
- Samsara Inc. (NYSE: IOT) gained 30.3% to $24.77 after the company reported better-than-expected first-quarter results and raised its FY24 outlook.
- MongoDB, Inc. (NASDAQ: MDB) shares rose 29.8% to $381.69 after the company reported upbeat results for its first quarter and issued strong projections.
- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 25.2% to $2.28.
- Universal Security Instruments, Inc. (NYSE: UUU) gained 24.6% to $3.0534.
- The Chemours Company (NYSE: CC) jumped 24.5% to $33.76 after the company announced it agreed to sell its Glycolic Acid business to PureTech Scientific for $137 million.
- eHealth, Inc. (NASDAQ: EHTH) rose 22.5% to $8.42.
- Digital Ally, Inc. (NASDAQ: DGLY) shares gained 21.2% to $4.81 after the company announced its subsidiary, Kustom Entertainment, entered into a business combination agreement with Clover Leaf Capital Corp.
- Pioneer Power Solutions, Inc. (NASDAQ: PPSI) rose 20.3% to $6.75 after the company announced that a major global automaker has transacted for multiple e-Boost units to support the initial rollout of autonomous EVs in several cities.
- CBAK Energy Technology, Inc. (NASDAQ: CBAT) gained 19.6% to $1.2086.
- Quanex Building Products Corporation (NYSE: NX) jumped 19.4% to $25.17 following upbeat quarterly earnings.
- LAVA Therapeutics N.V. (NASDAQ: LVTX) shares gained 18.3% to $2.25. LAVA Therapeutics reported selection by Janssen of lead Gamma-Delta T-Cell engager bispecific antibody to move toward clinical development.
- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) climbed 17.7% to $4.64.
- Connect Biopharma Holdings Limited (NASDAQ: CNTB) gained 17.5% to $1.29 as the company disclosed long-term data from the maintenance period through week 48 of CN002 Phase 2 icanbelimod trial in patients with moderate-to-severe ulcerative colitis.
- DISH Network Corporation (NASDAQ: DISH) gained 17.3% to $7.36 following a Bloomberg report suggesting Amazon is in talks with Verizon, Dish and T-Mobile to offer a free or low-cost mobile service to U.S. Prime members.
- Digital Media Solutions, Inc. (NYSE: DMS) rose 17.2% to $0.4101.
- Rain Oncology Inc. (NASDAQ: RAIN) shares gained 16.7% to $1.2950. Rain Oncology recently issued update and outlined strategic priorities of milademetan clinical programs.
- Diversified Healthcare Trust (NASDAQ: DHC) rose 14.6% to $1.6733. Diversified Healthcare Trust Director Adam D Portnoy acquired a total 3,154,641 shares an average price of $1.38.
- PacWest Bancorp (NASDAQ: PACW) jumped 13.5% to $7.63.
- 3D Systems Corporation (NYSE: DDD) gained 12.7% to $9.40. 3D Systems confirmed its submission of a proposal to combine with Stratasys.
- Kintara Therapeutics, Inc. (NASDAQ: KTRA) surged 12.3% to $3.4687.
- Lululemon Athletica Inc. (NASDAQ: LULU) rose 12% to $367.76 as the company reported better-than-expected earnings and sales results for its first quarter. For the full fiscal year, Lululemon sees revenue coming in a range of $9.44 billion to $9.51 billion, which would be up 17% year-over-year at the mid-point. Full-year earnings per share are expected to be in a range of $11.74 to $11.94.
- Stratasys Ltd. (NASDAQ: SSYS) rose 10.2% to $16.05 after the company received an unsolicited non-binding indicative proposal from 3D Systems Corporation.
- Chico's FAS, Inc. (NYSE: CHS) gained 9.4% to $4.9350.
- Macy's, Inc. (NYSE: M) climbed 8.1% to $14.87. Macy's reported a first-quarter FY23 sales decline of 7% year-on-year to $4.98 billion.
- Dell Technologies Inc. (NYSE: DELL) shares gained 5% to $47.76 following results for the first quarter.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares dropped 50.1% to $0.8227 after dropping over 20% on Thursday.
- Oncorus, Inc. (NASDAQ: ONCR) shares dropped 38.2% to $0.1121. Oncorus announced workforce reduction plan of 55 employees.
- SentinelOne, Inc. (NYSE: S) shares dipped 36.5% to $13.16 after the company reported worse-than-expected first-quarter sales and issued weak second-quarter guidance.
- SunCar Technology Group Inc. (NASDAQ: SDA) fell 24% to $32.92.
- PagerDuty, Inc. (NYSE: PD) fell 18% to $22.75 after the company issued weak revenue guidance.
- SciSparc Ltd. (NASDAQ: SPRC) declined 14.5% to $0.71. SciSparc announced successful final Phase IIa results, meeting end points of its Phase IIa Alzheimer disease patients with agitation trial.
- ROC Energy Acquisition Corp. (NASDAQ: ROC) dropped 14.4% to $6.96.
- TRxADE HEALTH, Inc. (NASDAQ: MEDS) fell 13.2% to $0.3380 after surging 39% on Thursday. TRXADE HEALTH recently reported worse-than-expected first-quarter sales results.
- Nexalin Technology, Inc. (NASDAQ: NXL) fell 13.2% to $0.8010.
- Guidewire Software, Inc. (NYSE: GWRE) dipped 13.1% to $72.00 after the company reported mixed third-quarter financial results and issued FY23 revenue guidance below the consensus estimate.
- Tilly's, Inc. (NYSE: TLYS) fell 11.6% to $6.52 after the company reported worse-than-expected first-quarter financial results and issued second-quarter guidance below estimates.
- Kymera Therapeutics, Inc. (NASDAQ: KYMR) dropped 10.3% to $26.35.
- BiomX Inc. (NYSE: PHGE) declined 9.4% to $0.3797.
- IonQ, Inc. (NASDAQ: IONQ) fell 9.1% to $9.74.
- T-Mobile US, Inc. (NASDAQ: TMUS) dropped 8.8% to $126.74.
- Sight Sciences, Inc. (NASDAQ: SGHT) declined 8.3% to $8.77.
- ChargePoint Holdings, Inc. (NYSE: CHPT) shares dropped 3% to $9.47 after the company reported first-quarter results and issued weak sales guidance for the current quarter.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Bitcoin, Ethereum Gain Following Jobs Data; Injective Emerges As Top Gainer
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.